Focus

PATRIOT ANNOUNCES CLOSING OF C$69 MILLION STRATEGIC INVESTMENT, OFFTAKE AND STRATEGIC PARTNERSHIP WITH VOLKSWAGEN AND POWERCO

VANCOUVER,BC,Jan. 22,2025-- January 22,2025 – Sydney,Australia Patriot Battery Metals Inc. (the "Company"or "Patriot") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased

Focus

Jan 26, 2025

XAG and Chia Tai Present Smart Agriculture Solutions to Enhance the Capabilities of Thai Farmers

KANCHANABURI,Thailand,Jan. 22,2025-- XAG made a noteworthy debut at the 10th Chia Tai Fair,showcasing a comprehensive suite of smart agriculture solutions,including the autonomous drones,autopilot con

Focus

Jan 26, 2025

To answer three key questions about economic globalization

BEIJING,Jan. 22,2025-- A report from People\'s Daily: In the face of a sluggish world economic recovery,the rising threat of protectionism,and the widening gap between the rich and the poor,discussion

Focus

Jan 26, 2025

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

Recorded Q4\'24 consolidated revenue of KRW 1.26 trillion Recorded FY\'24 consolidated revenue of KRW 4.55 trillion

Focus

Jan 26, 2025

Hyundai ADM Unveils a "New Paradigm in Cancer Treatment" - Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks

SEOUL,South Korea,Jan. 22,2025-- HyundaiADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M,developed from the well-kno

Focus

Jan 26, 2025

Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers

HONG KONG,Jan. 22,2025-- Today,Lepu Biopharma Co.,Ltd (Stock Code: 02157.HK) announced that it has entered into anexclusive licensing agreement with ArriVent BioPharma,Inc.for MRG007,a Potential Best-

Focus

Jan 26, 2025

1 ... 93 94 95 96 97 98 99 ... 117